110 likes | 233 Views
Policy Development and Guidance . Jon Clark OPS Associate Director for Policy Development. GMP for 21st Century . Some CMC guidance documents are out of synchronization with new thinking Guidance process has strong and weak points Strength is in technical input from staff scientists
E N D
Policy Development and Guidance Jon Clark OPS Associate Director for Policy Development
GMP for 21st Century • Some CMC guidance documents are out of synchronization with new thinking • Guidance process has strong and weak points • Strength is in technical input from staff scientists • Weakness is in decision making process for drafts
Draft cycling CMCCC Body Review Teams CMCCC Body CMCCCWorking Group OPS Edit Legal Edit Public Comment
Time Consuming Process • Rapid change in FDA thinking • Leaves slower efforts to “catch up” • Guidance development is a slower process • Investment of Time • Documents may be slow, but they have momentum • Guidance Content and New Direction are managed by different groups
Actions Taken • Move coordinating and decision making from CMCCC working group to OPS Office • OPS Coordinating Committee (OPS CC) • Moves Guidance content management to OPS • Disband CMCCC • Mandate OPS CC to recruit technical input from scientists
New Process Science input from selected Teams OPS CC OPS Edit Legal Edit Public Comment
Synchronization Effort • Revision of drafts • Public comment recycle • Withdrawal of Documents • Mainly for finalized Guidance documents • Enforcement Discretion • Guidance to address regulation requirements
Consider Options OTG • Other Than Guidance • Question and Answer Format • Post on public Internet • Keep it Simple • Manual of Policy and Procedure (MAPP) • If/Then format-Directed toward OPS staff • Publicly available • More rapid and flexible
Guidance • Risk based approach • Reverse recent tendency toward proscription and prescription • Manufacturer chooses technology and approach to problem solving • Focus efforts on assurance of reliable product quality and not technology
Input to Our Processes • What do you think? • Is there potential gain from formation of a “Fact Finding Group” to help us determine how we move toward the “Desired State?” • Do we need all the Guidances? • Where are they incongruent? • Provide advice as to what Guidance Industry needs as we work toward a new regulatory paradigm. • Prioritization